BR58 cell line
RECENTLY UPDATED

Datasheet

References (0)

Inventor Info

Info

Catalogue Number	157975
Antigen/Gene or Protein Targets	Ovary Cancer
Host	Human
Tissue	Breast
Disease Keywords	Ovary Cancer
Model	Tumour line
Relevance	This is an ovary cancer patient's derived cell line. Histology of serous papillary carcinoma. The line is derived from breast metastasis and it is positive for the BRCA1 c.68_69delAG, p.Glu23Valfs∗17 (185delAG) mutation. When implanted to NSG mice it forms tumors. This line can serve as a platform for drug screening for cancer cells in vitro and in vivo.
Production Details	The cells were derived from metastasis (pleural effusion) in a patient with serous papillary carcinoma.
Research Area	Cancer, Drug Discovery & Development
Recommended Growing Conditions	The base medium for this cell line is DMEM with 10% bovine serum.

There are 0 reference entries for this reagent.

Add a reference

Add a reference

No inventors are currently linked to this reagent.

Add an inventor

	Hadassah Medical Center
	3 reagents listed on Ximbio

	Hadasit Medical Research Services and Development Ltd.
	3 reagents listed on Ximbio

For all commercial and licensing enquiries including commercial research applications.

Make Enquiry

This reagent can be obtained from the following supplier. Click through to their website for more details.